HJLI News and Press, Hancock Jaffe Laboratories Inc. From 06/19/19

VenoValve Presentation on June 23, 2019 in Orlando, Florida IRVINE, CA / ACCESSWIRE / June 19, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that Dr. Jorge Hernando Ulloa, HJLI's ...

Six Patients Now Part of First-in-Human Bogota Study IRVINE, CA / ACCESSWIRE / June 13, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, has successfully implanted the VenoValve in an additional patie...

Hancock Jaffe Laboratories (NASDAQ: HJLI ) has priced public offering of 3.62M common shares at $1.07, for expected total gross proceeds of ~$3.9M. More news on: Hancock Jaffe Laboratories, Inc., Healthcare stocks news, Read more ...

Synlogic (NASDAQ: SYBX ) +26%  as Ginkgo Bioworks to invest $80M . More news on: Synlogic, Inc., Bridgeline Digital, Inc., MagnaChip Semiconductor Corporation, , Stocks on the move Read more ...

Company Fortifies Balance Sheet Ahead of Key Milestones IRVINE, CA / ACCESSWIRE / June 12, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, today announced the pricing of its public offering of 3,6...

Gainers:  Provention Bio (NASDAQ: PRVB ) +296% . Vuzix Corporation (NASDAQ: VUZI ) +54% . Xynomic Pharmaceuticals Holdings (NASDAQ: XYN ) +46% . Tableau Software (NYSE: DATA ) +35% . Hi-Crush (NYSE: HCR ) +31% . Beyond Meat (NASDAQ: BYND ) +24% . Workhorse Group (NASDAQ: WKHS ) ...

Beyond Meat (NASDAQ: BYND ) +28%  as investors eye fast-food chain potential. More news on: Beyond Meat, Inc., La Jolla Pharmaceutical Company, Hancock Jaffe Laboratories, Inc., Stocks on the move, Read more ...

Reflux Significantly Reduced in Four out of Five Patients IRVINE, CA / ACCESSWIRE / June 7, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, today announced early positive results from its first-in-...

Implantations Expected to Take Place Later this Month IRVINE, CA / ACCESSWIRE / June 3, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that it has enrolled two additional patients fo...

Initial Patient Data to be Released on June 7th for First-In-Human VenoValve Study IRVINE, CA / ACCESSWIRE / May 28, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, will report initial data on the ...